American College of Clinical Pharmacy
      Search      Cart
         

IDSAP 2023 Book 1 SSTI, Bone, and Joint Infections and Outpatient Antimicrobial Stewardship


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to receive member pricing. Your ASHP membership number and expiration date are required.

In the IDSAP release SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship experienced practitioners and scholars review the management of common infectious syndromes across the continuum of care, highlighting clinical conundrums, unique aspects of outpatient antimicrobial stewardship, and current evidence for therapeutic decision-making.

P. Brandon Bookstaver, Pharm.D., FCCP, FIDSA, BCIDP
Bookstaver

The target audience for the book is board-certified infectious diseases pharmacists caring for adult or pediatric patients in the acute or ambulatory setting. SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship contains four learning modules with a total available 14.0 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair P. Brandon Bookstaver, Pharm.D., FCCP, FIDSA, BCIDP.

The first module focuses on the management of osteomyelitis and skin and soft tissue infections with chapters that discuss diagnostic considerations, controversies in management, and key evidence of anti-infective therapy. The second module focuses on septic arthritis, prosthetic joint infections (PJIs), and antimicrobial stewardship in dentistry. Diagnostic and treatment considerations leveraging current evidence are discussed for septic arthritis and PJIs. Expert interprofessional authors uniquely discuss strategies and implementation of stewardship in dentistry. The third module includes chapters highlighting outpatient pediatric stewardship strategies among commonly encountered infections and a recorded webcast on stewardship in pediatric patients. The final module includes two interactive cases that explore the topics of oral antibiotics in osteomyelitis and long-acting lipoglycopeptides in skin and soft tissues infections.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3-5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Interactive cases (a series of webpages, each introduced by a sample case-based question)
  • Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be rea

Release Date: May 15, 2023
BCIDP Deadline: November 15, 2023
ACPE Deadline: May 15, 2026

ISBN: 978-1-952291-72-2
Publication Year: 2023
Format: PDF and ePub
Number of Pages: 200

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCIDP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.